What WinVision does

WinVision is the ophthalmic pharmaceutical division of Micropolis Lifesciences Pvt. Ltd., a privately held Indian pharma group headquartered in Panchkula, Haryana. The company manufactures a focused range of eye-care formulations spanning antibiotic and anti-inflammatory eye drops (BACTWIST series), lubricant and dry-eye drops (LUBRIKEY, TEARPOLIS, PEGWIN), anti-allergy drops (OLOTWIST), steroid and NSAID drops (LOTEKEY, FLURWIN, NEPATWIST), antifungal drops (NATAVISION), intraocular-pressure management drops (TIMOTWIST), adjunct gels (GANCITWIST, TEARPOLIS EYE GEL), ophthalmic ointments, softgel antioxidant capsules, syrups, and an incoming eye-health gummy line. Manufacturing is conducted in a single WHO-GMP certified facility in Panchkula, with H.A.C.C.P. food-safety compliance also claimed; the R&D function focuses on formulation innovation in ophthalmology rather than novel-molecule development.

The company's revenue model is centered on a PCD (Propaganda Cum Distribution) pharma franchise system: WinVision grants monopoly territorial distribution rights to franchise partners, supplies them with marketing collateral (visual aids, sample packs, doctor lists, promotional merchandise), and sells finished ophthalmic products through that network. Customers include PCD franchisees, doctors and ophthalmologists, hospitals and clinics, pharmaceutical wholesalers, retailers, medical representatives, and area/regional managers. Pricing is quote-based and not publicly disclosed, with multi-year franchise contracts underlying the business relationship.

Operating geographies are domestic-only, with franchise recruitment actively marketed across states including Gujarat, Telangana, Tamil Nadu, West Bengal, Punjab, Jammu & Kashmir, Maharashtra, and Madhya Pradesh. Sister concerns Gynopolis (gynecology) and Win Fertility operate under the same Micropolis Lifesciences parent, giving the group a multi-therapeutic footprint. The company has been in operation for over 20 years with no public funding rounds, no acquisitions, and no disclosed revenue figures.

Name

WinVision

Legal name

WinVision (A Division of Micropolis Lifesciences Pvt. Ltd.)

Website

https://winvisionindia.com

Company type

Private

Operating status

Operating

Short description

WinVision is the ophthalmic pharmaceutical division of Micropolis Lifesciences Pvt. Ltd., manufacturing eye drops, capsules, ointments, syrups, and gummies at a WHO-GMP facility in Panchkula and selling through a PAN India PCD franchise network.

Ownership category

akta.pro rank

Product category

Ophthalmic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Ophthalmology Specialty Pharmaceuticals (HLAIACAK)

akta.pro secondary industry

Ophthalmology Pharmaceuticals (HLAIAAAL)

Keywords

• Ophthalmic pharmaceuticals
• Eye drops manufacturing
• PCD pharma franchise
• Eye care products
• Ophthalmic formulations

Headquarters

HQ city

Panchkula

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: WinVision generates revenue through manufacturing and distributing ophthalmic pharmaceutical products including eye drops, capsules, tablets, syrups, ointments, and gummies. Revenue flows through PCD franchise partners who purchase products for redistribution in their assigned territories.
2. PCD Franchise Rights: The company offers monopoly rights to franchise partners for exclusive distribution in assigned geographic areas. Franchise partners invest in distribution rights and purchase products for resale.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

WinVision manufactures and distributes a comprehensive portfolio of ophthalmic pharmaceutical products including eye drops, capsules, tablets, syrups, ointments, and gummies. The company operates on a PCD (Propaganda Cum Distribution) pharma franchise model across India, offering monopoly territorial rights to franchise partners along with marketing collateral, training, and dedicated logistics for product delivery.

Product overview

WinVision is a pharmaceutical company specializing in ophthalmic (eye care) products, operating as a division of Micropolis Lifesciences Pvt. Ltd. The company offers a comprehensive portfolio of eye care formulations organized across five main product categories: Eye Drops (including antibiotic, anti-inflammatory, anti-allergy, lubricant, and antifungal formulations), Eye Ointments, Capsules (soft gelatin capsules for oral eye health supplementation), Gummies (edible eye health supplements), and Syrups. The eye drops portfolio includes combination products like BACTWIST series (BACTWIST, BACTWIST-BF, BACTWIST-DX, BACTWIST-KT, BACTWIST-LT, BACTWIST-PD), LUBRIKEY series (LUBRIKEY, LUBRIKEY PLUS, LUBRIKEY ULTRA), OLOTWIST series (OLOTWIST, OLOTWIST KT, OLOTWIST-LS), TEARPOLIS series (TEARPOLIS, TEARPOLIS PLUS, TEARPOLIS EYE GEL), and specialty products like CATAKEY, NEPATWIST, LOTEKEY, TIMOTWIST, NATAVISION, and others. The capsule line includes WINVISION S.G.C and WINVISION FORTE S.G.C softgel capsules. The company operates on a PCD (Propaganda Cum Distribution) pharma franchise business model offering monopoly rights to distribution partners across India.

Differentiator

Problem solved

Functional benefit

Products and services

• BACTWIST Eye Drops
• BACTWIST-BF Eye Drops
• BACTWIST-DX Eye Drops
• BACTWIST-KT Eye Drops
• BACTWIST LT Eye Drops
• LUBRIKEY Eye Drops
• LUBRIKEY PLUS Eye Drops
• LUBRIKEY ULTRA Eye Drops
• OLOTWIST Eye Drops
• OLOTWIST KT Eye Drops
• OLOTWIST-LS Eye Drops
• TEARPOLIS Eye Drops
• TEARPOLIS PLUS Eye Drops
• TEARPOLIS EYE GEL
• CATAKEY Eye Drops
• NEPATWIST Eye Drops
• LOTEKEY Eye Drops
• TIMOTWIST Eye Drops
• TOBATWIST Eye Drops
• GATPOLIS Eye Drops
• NAPHAPOLIS Eye Drops
• FLURWIN Eye Drops
• BACSTATIK Eye/Ear Drops
• NATAVISION Eye Drops
• PEGWIN Eye Drops
• RIPDRY Eye Drops
• GANCITWIST EYE GEL
• AZIMICRO EYE OINTMENT
• WINVISION S.G.C Capsules
• WINVISION FORTE S.G.C Capsules
• WINVISION GUMMIES

Quantifiable outcome

• Products manufactured and dispatched on time through dedicated logistics team
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered minor and core.

• GynopolisminorOthersGynopolis is listed as a sister concern of WinVision. It appears to be a related company under the same corporate umbrella, possibly operating in a different therapeutic area (gynecology based on the name).
• Win FertilityminorOthersWin Fertility is listed as a sister concern of WinVision, operating under the Micropolis Lifesciences Pvt. Ltd. umbrella. It focuses on fertility-related pharmaceutical products.
• Micropolis Lifesciences Pvt. Ltd.coreOthersWinVision is a division of Micropolis Lifesciences Pvt. Ltd. The parent company owns and operates multiple pharmaceutical divisions including WinVision (ophthalmics) and Win Fertility (fertility products).

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Alembic Pharmaceuticals: Indian pharmaceutical company with a dedicated ophthalmic division offering eye drops and related formulations. Comparable as a broad incumbent with overlapping ophthalmic products and Indian prescriber relationships.
• Intas Pharmaceuticals: Large Indian pharmaceutical company with ophthalmic and other therapeutic segments. Competes with WinVision in the ophthalmic space with deeper resources and broader portfolio.
• Lupin Limited: Top Indian pharma company with ophthalmic and other therapeutic segments. Operates as a broad incumbent with deeper resources, competing on similar ophthalmic molecules and prescribers as WinVision.
• Alcon: Global leader in eye care across surgical, vision care, and ophthalmic pharmaceuticals. Broad incumbent providing advanced ophthalmic drugs, contact lenses, and surgical devices that compete with portions of WinVision's product range, particularly in India through its local presence.
• Sun Pharmaceutical Industries: India's largest pharma company with a substantial ophthalmic portfolio (including SUN pharma's branded generics and combination products). It is a broad incumbent that competes with WinVision across the ophthalmic molecule space but at significantly larger scale.
• Cipla Limited: Major Indian pharmaceutical company with ophthalmic and respiratory divisions, offering eye drops and related products through extensive field force distribution. Comparable as a broad incumbent targeting similar Indian prescribers with overlapping molecules.
• Bausch + Lomb: Global ophthalmic-focused company offering pharmaceuticals, contact lenses, and surgical products. Comparable as a broad incumbent with significant ophthalmic pharma overlap that competes for prescribers and shelf space in India.

Direct peers

• Ajanta Pharma: Indian pharmaceutical company with a significant ophthalmic franchise business offering PCD opportunities and a wide ophthalmic product range. Closely comparable to WinVision in its PCD-driven ophthalmic specialty positioning in India.
• Centaur Pharmaceuticals: India-focused pharmaceutical company with a strong ophthalmology franchise (e.g., Moxicip, Lupituss) and active PCD/distribution model. Closely comparable as a mid-sized Indian ophthalmic specialist using similar franchise distribution.
• Entod Pharmaceuticals: India-focused ophthalmic specialty pharma with a strong PCD franchise network across India. Directly comparable to WinVision in therapeutic focus, target customers, and franchise-driven distribution model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WinVision